Dofequidar fuMarate
- CAS No.
- 153653-30-6
- Chemical Name:
- Dofequidar fuMarate
- Synonyms
- Dofequidar (2E)-2-butenedioate (1:1);Dofequidar,Inhibitor,MS209,CD243,ABCB1,MS 209,Dofequidar fumarate,Multidrug resistance protein 1,Cluster of differentiation 243,P-gp,P-glycoprotein,MDR1,inhibit,Pgp
- CBNumber:
- CB92627774
- Molecular Formula:
- C34H35N3O7
- Molecular Weight:
- 597.6576
- MDL Number:
- MFCD00925095
- MOL File:
- 153653-30-6.mol
Dofequidar fuMarate price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
ChemScene | CS-2041 | Dofequidar fumarate 99.99% | 153653-30-6 | 10mg | $156 | 2021-12-16 | Buy |
ChemScene | CS-2041 | Dofequidar fumarate 99.99% | 153653-30-6 | 5mg | $96 | 2021-12-16 | Buy |
ChemScene | CS-2041 | Dofequidar fumarate 99.99% | 153653-30-6 | 50mg | $600 | 2021-12-16 | Buy |
ApexBio Technology | B1167 | Dofequidar fumarate | 153653-30-6 | 50mg | $805 | 2021-12-16 | Buy |
ChemScene | CS-2041 | Dofequidar fumarate 99.99% | 153653-30-6 | 100mg | $1020 | 2021-12-16 | Buy |
Dofequidar fuMarate Chemical Properties,Uses,Production
Biological Activity
dofequidar fumarate is a multidrug-resistant (mdr) - reversal agent [1].dofequidar fumarate is a quinoline derivative and has highly potent reversing effect on multidrug-resistant tumor cells. it prevents the transport of antitumor drugs through interacting with the drug-efflux pump p-glycoprotein directly and thereby reverses mdr. in vincristine (vcr)-resistant p388/vcr cells and adriamycin (adm)- resistant p388/adm cells, dofequidar fumarate at 1μm and 3μm can completely reverse the drug resistance. it also shows significant effects on the mdr k562 cells. furthermore, in mice model bearing hct-15 xenografts, combination therapy of dofequidar fumarate and docetaxel induces remarkable tumor growth inhibition. dofequidar fumarate also shows significant reversing effect in mcf-7/adm-bearing mice [1, 2].
References
[1] sato w, fukazawa n, nakanishi o, et al. reversal of multidrug resistance by a novel quinoline derivative, ms-209. cancer chemotherapy and pharmacology, 1995, 35(4): 271-277.
[2] naito m, matsuba y, sato s, et al. ms-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models. clinical cancer research, 2002, 8(2): 582-588.
Dofequidar fuMarate Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32957 | 60 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32161 | 58 |
HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6312 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38631 | 58 | |
Aladdin Scientific | +1-+1(833)-552-7181 | sales@aladdinsci.com | United States | 52924 | 58 |
Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131957 | 58 |
Haoyuan Chemexpress Co., Ltd. | 021-58950125 | info@chemexpress.com | China | 7552 | 61 |
MedChemexpress LLC | 021-58955995 | sales@medchemexpress.cn | United States | 4861 | 58 |
SPIRO PHARMA | eric_feng1954@126.com | China | 9248 | 55 | |
Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9806 | 58 |
View Lastest Price from Dofequidar fuMarate manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
2024-11-19 | Dofequidar fumarate
153653-30-6
|
US $33.00-77.00 / mg | 99.43% | 10g | TargetMol Chemicals Inc. | |||
2024-11-19 | Dofequidar fumarate
153653-30-6
|
US $33.00-77.00 / mg | 99.43% | 10g | TargetMol Chemicals Inc. |
- Dofequidar fumarate
153653-30-6
- US $33.00-77.00 / mg
- 99.43%
- TargetMol Chemicals Inc.
- Dofequidar fumarate
153653-30-6
- US $33.00-77.00 / mg
- 99.43%
- TargetMol Chemicals Inc.